Mangaceuticals Inc. (MGRX)
NASDAQ · Healthcare
Mangaceuticals Inc. Income Statement 2022–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenue | 456,021 | 615,873 | 731,493 | 8,939 |
| Gross Profit | 250,386 | 379,964 | 431,501 | 4,850 |
| Profitability | ||||
| Operating Income | -18.0M | -8.0M | -9.2M | -2.0M |
| EBITDA | — | -8.0M | -9.2M | — |
| Net Income | -20.6M | -8.7M | -9.2M | -2.0M |
| Per Share Data | ||||
| EPS (diluted) | — | — | — | — |
| Shares Outstanding (dil.) | 10M | 2M | 1M | 11M |
Mangaceuticals Inc. Income Statement — FAQ
Mangaceuticals Inc. (MGRX) income statement over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MGRX's income statement history?
The chart and table above show Mangaceuticals Inc.'s income statement by year and by quarter, including the growth rate.